BioAtla annual free cash flow
2019
2020
2021
2022
2023
2024
BioAtla Free Cash Flow (FCF) History (BCAB)
BioAtla reported −$71.9M in free cash flow for fiscal 2024, an increase of $32.2M from the previous fiscal year.
View full BioAtla company overviewBioAtla free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$71.9M | $32.2M | — | — |
| 2023 | 2023-12-31 | −$104.1M | −$13.4M | — | — |
| 2022 | 2022-12-31 | −$90.7M | −$27.6M | — | — |
| 2021 | 2021-12-31 | −$63.1M | −$26.2M | — | −21046.00% |
| 2020 | 2020-12-31 | −$36.9M | −$25.8M | — | — |
| 2019 | 2019-12-31 | −$11.2M | — | — | — |
BioAtla quarterly free cash flow
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q1 2025 | 2025-03-31 | −$16.3M | $14.5M | — | — |
| Q4 2024 | 2024-12-31 | −$16.8M | $13.1M | — | — |
| Q3 2024 | 2024-09-30 | −$5.1M | $22.2M | — | — |
| Q2 2024 | 2024-06-30 | −$19.2M | $4.9M | — | — |
| Q1 2024 | 2024-03-31 | −$30.8M | −$8.1M | — | — |
| Q4 2023 | 2023-12-31 | −$29.9M | −$5.6M | — | — |
| Q3 2023 | 2023-09-30 | −$27.4M | −$3.3M | — | — |
| Q2 2023 | 2023-06-30 | −$24.1M | −$7.0M | — | — |
| Q1 2023 | 2023-03-31 | −$22.7M | $2.4M | — | — |
| Q4 2022 | 2022-12-31 | −$24.4M | −$3.3M | — | — |
| Q3 2022 | 2022-09-30 | −$24.1M | −$11.2M | — | — |
| Q2 2022 | 2022-06-30 | −$17.1M | −$3.3M | — | — |
| Q1 2022 | 2022-03-31 | −$25.1M | −$9.7M | — | — |
| Q4 2021 | 2021-12-31 | −$21.0M | −$6.6M | — | — |
| Q3 2021 | 2021-09-30 | −$12.8M | $2.7M | — | — |
| Q2 2021 | 2021-06-30 | −$13.8M | −$10.7M | — | −4593.33% |
| Q1 2021 | 2021-03-31 | −$15.5M | −$11.7M | — | — |
| Q4 2020 | 2020-12-31 | −$14.4M | — | — | — |
| Q3 2020 | 2020-09-30 | −$15.6M | — | — | — |
| Q2 2020 | 2020-06-30 | −$3.1M | — | — | — |
| Q1 2020 | 2020-03-31 | −$3.8M | — | — | — |
BioAtla free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$11.2M to −$71.9M, a net decrease of $60.8M. BioAtla's latest reported quarter, Q1 2025, generated −$16.3M in free cash flow, an increase of $14.5M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review BioAtla filings at SEC.gov ↗